TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
Cells · 05.03.2026 · 15 (5) · 466
DOI: 10.3390/cells15050466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 05.03.2026. Verfasst von Joumana Al Akhdar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Koç University, 34450 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, Osteogenesis, Cell Differentiation, Muscle, Smooth, Vascular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TÜBİTAK 1002 project, TÜBİTAK 1001, Koç University, School of Medicine.
Abstract (Originalsprache)
Background
Cardiovascular diseases (CVDs) are the leading global cause of mortality, with vascular calcification (VC) as a major predictor of adverse outcomes. Although vascular smooth muscle cells (VSMCs) are established contributors, the role of endothelial cells (ECs), particularly via the endothelial–mesenchymal transition (EndMT) and exosome signaling, remains less defined.
Objective
This study investigated whether the gut microbiota-derived metabolite Trimethylamine-N-oxide (TMAO) induces EndMT in ECs and whether exosomes from TMAO-treated ECs regulate the VSMC phenotype and calcification.
Methods
Human umbilical vein endothelial cells (HUVECs) were exposed to TMAO at physiological and pathological levels (10–50 µM). EndMT markers were analyzed by Western blotting and qPCR. Exosomes were isolated, characterized, and applied to HAVSMCs in graded doses. Osteogenic and contractile markers, β-catenin signaling, and calcification were quantified. Exosomal miR-30 and miR-222 were studied.
Results
TMAO triggered dose-dependent EndMT, decreasing CD31/VE-cadherin and increasing α-SMA, N-cadherin, and vimentin. Exosomes from TMAO-treated ECs reprogrammed VSMCs, downregulating contractile proteins and upregulating RUNX2, OPN, TNAP, and β-catenin, causing calcium accumulation. These exosomes displayed elevated miR-222 and reduced miR-30, changes that activated β-catenin signaling and promoted the osteogenic reprogramming of VSMCs.
Conclusions
Pathophysiological TMAO levels induce EndMT and mediate the formation of exosomes, which drive the osteogenic reprogramming and calcification of VSMCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Health Sciences, Koç University, 34450 Istanbul, Türkiye.
- Research Center for Translational Medicine, (KUTTAM), Koç University, 34450 Istanbul, Türkiye.
- Department of Biochemistry, School of Medicine, Koç University, 34450 Istanbul, Türkiye.
ORCID-Profile: Joumana Al Akhdar, Melike Nur Yangın Yılmaz, Kemal Baysal
Förderung
- TÜBİTAK 1002 project
- TÜBİTAK 1001
- Koç University, School of Medicine
Zitieren
APA
Al Akhdar, J., Yangın Yılmaz, M. N., & Baysal, K. (2026). TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification. Cells, 15(5), 466. https://doi.org/10.3390/cells15050466
Vancouver
Al Akhdar J, Yangın Yılmaz MN, Baysal K. TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification. Cells. 2026;15(5):466. doi:10.3390/cells15050466
BibTeX
@article{AlAkhdar2026,
author = {Al Akhdar, Joumana and Yangın Yılmaz, Melike Nur and Baysal, Kemal},
title = {TMAO-Triggered Endothelial–Mesenchymal Transition and Microvesicle Release as Mediators of Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification},
journal = {Cells},
year = {2026},
volume = {15},
number = {5},
pages = {466},
doi = {10.3390/cells15050466}
}
EUVIMED